483 Changzhou Ruiming Pharmaceuticals Sep 2018

483 Changzhou Ruiming Pharmaceuticals Sep 2018

Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Changzhou Ruiming Pharmaceuticals - Changzhou, China facility and issued inspectional observations (via FDA 483) on 13 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Sep 2018
  • Location: Changzhou, China
  • FEI: 3007086821
Add To Cart